ImmunoPrecise will be at the upcoming BIO International Convention in Boston and looks forward to meeting with you.
- B cell Selection Technologies
- Advanced Hybridoma Development
- Preferred OmniAb® Service Provider
- Phage Display
- Antibody Characterization & Optimization
- Human Monoclonals
- Custom Naïve & Immune Human Libraries
- Protein Expression
ImmunoPrecise Antibodies Ltd. (IPA) is a full-service, antibody discovery CRO focused on the next generation of antibody discovery. We aim to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials.
IPA is a single source provider of services for the complete antibody discovery value chain. We offer the most comprehensive collection of antibody discovery platforms in the industry, combined with state of the art lead candidate optimization and characterization. This allows us to assist clients from the moment they identify a therapeutic target to the preparation of applying for investigation review of the clinical product.
BIO 2018 Information:
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotech centers and related organizations across the United States and over 30 other nations. BIO One-on-One Partnering™ is the most efficient way to do business in the biotech and pharma industry without traveling all over the world. #BIO2018
BIO 2018 will be held at the Boston Convention & Exhibition Center: 415 Summer St, Boston, MA 02210
For more information, please contact us.